$0.2550
-0.00500-1.92%
At close: -
$0.2494
-0.00560-2.20%
After Hours: 4:17 PM EDT
Comments
Loading...
Relmada Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:RLMD | Benzinga
Relmada Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 18
EPS Estimate
$-0.580
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Relmada Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Relmada Therapeutics (RLMD) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $-0.72 | $-0.64 | -12.5 % |
| Q2 | 2024-08-07 | $-0.59 | $-0.83 | 28.9 % |
| Q1 | 2024-05-08 | $-0.72 | $-0.88 | 18.2 % |
| Q4 | 2024-03-19 | $-0.84 | $-0.83 | -1.20 % |
Relmada Therapeutics (RLMD) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Relmada Therapeutics (NASDAQ:RLMD) reporting earnings?
Relmada Therapeutics (RLMD) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for Relmada Therapeutics (NASDAQ:RLMD)?
The Actual EPS was $-0.72, which missed the estimate of $-0.64.
What were Relmada Therapeutics’s (NASDAQ:RLMD) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.